Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 27 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

Overall cancer mortality rates were 12.3% higher in persistent poverty counties versus all others, and 9.6% higher in persistent versus current poverty counties, with even greater disparities observed for specific cancer sites. Persistent poverty counties have exceptionally high cancer mortality, and targeted research, policy, and intervention efforts are needed to reduce these geographic disparities in cancer.Many studies have shown that patients with Alzheimer disease are at decreased risk of cancer, but this inverse relation is likely to be biased by surveillance and survival bias. They showed that higher levels of plasma amyloid-β were associated with a higher risk of cancer, suggesting a potential biological link between Alzheimer disease and cancer. In three prospective cohorts including eight types of cancer, the total number of SEMs was associated with increased risk of breast, lung, and mature B-cell cancers in pre-diagnostic blood samples. Low and high serum calcium resulted in increased risk, whereas high serum 25(OH)D was a protective factor.

Key findings

Why it matters

This summary highlights a study finding that higher levels of plasma amyloid-beta were linked to higher cancer risk, suggesting a possible biological link between Alzheimer's disease and cancer. It does not test any treatment, cure, or prevention for Alzheimer's disease.

Study details

How this study scored 27/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 2 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. 25 of the 93 points it could be judged on, which is 27 of 100. Total 27 of 100.25 of the 93 points we could judge = 27 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it. We have no data on senior author's track record and institution's track record, so those were left out: it earned 25 of the 93 points we could judge it on, which is 27 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Cancer Epidemiology Biomarkers & Prevention)
Journal's citation record 2 / 4 Cancer Epidemiology Biomarkers & Prevention: journal h-index 210 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 2 / 5 2020 — within 10 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 8 year(s) since 2020
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 25 / 93 Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 25 of the 93 points we could judge it on is 27 out of 100.
Total 27 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. This record has no authors, so the citation leaves them out. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Selected Articles from This Issue. (2020). Cancer Epidemiology Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.1841.29.10

Vancouver

Selected Articles from This Issue. Cancer Epidemiology Biomarkers & Prevention. 2020. doi:10.1158/1055-9965.1841.29.10.

BibTeX

@article{study2020-e9489aa9,
  title   = {{Selected Articles from This Issue}},
  journal = {Cancer Epidemiology Biomarkers \& Prevention},
  year    = {2020},
  doi     = {10.1158/1055-9965.1841.29.10},
  url     = {https://doi.org/10.1158/1055-9965.1841.29.10}
}

Related studies in Risk factors

Similar studies

More on Risk factors

See all studies in Risk factors →